Rafferty Asset Management
RCEL icon

Rafferty Asset Management’s Avita Medical RCEL Stock Holding History

Rafferty Asset Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51,600
Closed -$827K – 1188
2024
Q1 		$827K Buy
+51,600
New +$835K ﹤0.01% 864
2022
Q1 		– Sell
-36,178
Closed -$433K – 1309
2021
Q4 		$433K Buy
36,178
+16,155
+81% +$246K ﹤0.01% 1086
2021
Q3 		$355K Sell
20,023
-7,220
-27% -$136K ﹤0.01% 1108
2021
Q2 		$559K Sell
27,243
-2,053
-7% -$40.5K ﹤0.01% 1050
2021
Q1 		$581K Buy
+29,296
New +$681K ﹤0.01% 953

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rafferty Asset Management's RCEL Position: Q2 2024 in Review

Rafferty Asset Management sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 51,600 shares — an estimated $827K sold.

Rafferty Asset Management first reported a position in RCEL in Q1 2021 and held it in 5 quarters. The position peaked at $827K in Q1 2024. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Rafferty Asset Management reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Rafferty Asset Management sold 51,600 Avita Medical shares in Q2 2024, an estimated $827K.
  • Rafferty Asset Management first reported a position in Avita Medical in Q1 2021 and held it in 5 quarters.
  • Rafferty Asset Management's Avita Medical position peaked at $827K in Q1 2024.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.